What is the next dose of duloxetine (Cymbalta) for a patient currently taking 60 mg twice daily?

The patient is already at the maximum recommended dose

For a patient currently taking duloxetine (Cymbalta) 60 mg twice daily (120 mg/day total), there is no next dose—this is the maximum recommended dosage, and further dose escalation is not supported by evidence and has not been adequately evaluated for safety. 11

Key Dosing Information

The FDA-approved maximum dose of duloxetine is 60 mg twice daily (120 mg/day total) across all indications 11. Your patient is already at this ceiling dose.

Evidence Against Higher Doses

• No additional benefit above 60 mg/day: For most indications (diabetic neuropathic pain, fibromyalgia, chronic musculoskeletal pain), there is no evidence that doses higher than 60 mg/day confer additional significant benefit 111

• Higher doses = more adverse effects: Doses above 60 mg/day are associated with higher rates of adverse reactions without corresponding efficacy gains 11

• Safety not established: The FDA label explicitly states "The safety of doses above 120 mg/day has not been adequately evaluated" 11

Clinical Decision Algorithm at Maximum Dose

Since your patient is at 120 mg/day without adequate response, consider:

1. Reassess the diagnosis and treatment duration: Has the patient had an adequate trial? For neuropathic pain, this is 4 weeks at maximum dose 222. For depression, 6-8 weeks including 2 weeks at maximum tolerated dose 22

2. Switch to alternative first-line medication: Rather than exceeding the maximum dose, guidelines recommend switching to a different first-line agent (e.g., gabapentin, pregabalin, tricyclic antidepressants for neuropathic pain) 22

3. Add combination therapy: Consider adding one of the other first-line medications rather than increasing duloxetine further 22

4. Refer to specialist: If trials of first-line medications alone and in combination fail, referral to a pain specialist or multidisciplinary pain center is appropriate 22

Important Caveats

• Depression/anxiety exception: While 120 mg/day was shown to be effective for major depressive disorder and generalized anxiety disorder, there is still no evidence that doses greater than 60 mg/day confer additional benefits 11

• Tolerability concerns: The 60 mg BID dose has higher discontinuation rates due to adverse events compared to 60 mg once daily 34

• Do not exceed 120 mg/day: Going above this dose is off-label, unsupported by evidence, and potentially unsafe